These results support the notion that VEGF-A may play a key role as a proangiogenic factor in the COVID-19 pathological pathway, but in post-COVID-19 syndrome, VEGF-A is regulated more efficiently in patients with abnormal spirometry than in those with normal pulmonary function. The gene discussed is VEGFA; the disease is COVID-19.